Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Steven M. Paul currently holds 15,200 shares of Sage Therapeutics, Inc. (SAGE), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Steven M. Paul has been a net seller of SAGE stock. They have purchased $1.9M and sold $81.6M worth of shares.
Steven M. Paul's most recent insider trade was on Jun 10, 2026, when they sold 15,200 shares at $0.00 per share.
Steven M. Paul serves as Executive at Sage Therapeutics, Inc. (SAGE). They have executed 202 insider transactions totaling $83.6M over their tenure at the company.
Steven M. Paul holds the position of Executive at Sage Therapeutics, Inc., where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 21 years and currently hold a stake valued at $0.
Steven M. Paul has shown a selling trading pattern, with $1.9M in total purchases and $81.6M in total sales across all transactions. Their most recent activity indicates a tendency to reduce their position.
The largest transaction by Steven M. Paul was on Mar 18, 2024, when they sold $244.3M worth of KRTX shares. This transaction involved 757,045 shares at $322.73 per share.
Steven M. Paul currently owns 15,200 shares of Sage Therapeutics, Inc. (SAGE), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Steven M. Paul's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Steven M. Paul has 202 Form 4 filings on record as an insider at Sage Therapeutics, Inc..
Set alerts for Steven M. Paul and 40,000+ other insiders.